Tuesday, April 14, 2009

Dendreon’s Shares Come Back to Life on Prostate Cancer Data

The company says Provenge improved survival among men with advanced prostate cancer, but is holding off on providing details until late April.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)